Plexus (NASDAQ:PLXS – Get Free Report) issued an update on its third quarter earnings guidance on Wednesday morning. The company provided EPS guidance of $1.22-1.37 for the period, compared to the consensus EPS estimate of $1.09. The company issued revenue guidance of $960 million – $1 billion, compared to the consensus revenue estimate of $1.02 billion. Plexus also updated its Q3 2024 guidance to 1.220-1.370 EPS.
Plexus Stock Performance
Shares of PLXS traded down $0.91 during mid-day trading on Wednesday, hitting $95.67. 114,744 shares of the company traded hands, compared to its average volume of 117,256. Plexus has a 1 year low of $83.84 and a 1 year high of $114.06. The company has a debt-to-equity ratio of 0.15, a quick ratio of 0.62 and a current ratio of 1.52. The stock has a 50-day moving average price of $94.32 and a two-hundred day moving average price of $98.39. The stock has a market cap of $2.64 billion, a price-to-earnings ratio of 21.34 and a beta of 1.02.
Plexus (NASDAQ:PLXS – Get Free Report) last released its quarterly earnings results on Thursday, January 25th. The technology company reported $1.04 earnings per share for the quarter, missing the consensus estimate of $1.05 by ($0.01). Plexus had a net margin of 3.08% and a return on equity of 12.16%. The firm had revenue of $982.61 million for the quarter, compared to the consensus estimate of $982.57 million. During the same period in the previous year, the company earned $1.49 earnings per share. Plexus’s quarterly revenue was down 10.2% compared to the same quarter last year. Equities analysts anticipate that Plexus will post 4.25 earnings per share for the current year.
Wall Street Analysts Forecast Growth
Check Out Our Latest Analysis on Plexus
Insider Buying and Selling at Plexus
In other Plexus news, CEO Todd P. Kelsey sold 2,000 shares of Plexus stock in a transaction that occurred on Thursday, February 1st. The shares were sold at an average price of $94.30, for a total transaction of $188,600.00. Following the completion of the sale, the chief executive officer now directly owns 121,859 shares in the company, valued at approximately $11,491,303.70. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. In other news, CEO Todd P. Kelsey sold 2,000 shares of Plexus stock in a transaction dated Thursday, February 1st. The shares were sold at an average price of $94.30, for a total value of $188,600.00. Following the sale, the chief executive officer now owns 121,859 shares in the company, valued at $11,491,303.70. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, CFO Patrick John Jermain sold 2,532 shares of the company’s stock in a transaction dated Monday, January 29th. The stock was sold at an average price of $92.51, for a total transaction of $234,235.32. Following the transaction, the chief financial officer now owns 54,651 shares of the company’s stock, valued at approximately $5,055,764.01. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 32,453 shares of company stock valued at $3,112,875. 2.39% of the stock is currently owned by insiders.
Plexus Company Profile
Plexus Corp. provides electronic manufacturing services in the United States and internationally. It offers design, develop, supply chain, new product introduction, and manufacturing solutions, as well as sustaining services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors.
Read More
- Five stocks we like better than Plexus
- 3 Warren Buffett Stocks to Buy Now
- High-Yield Texas Instruments Could Hit New Highs Soon
- Investing in Commodities: What Are They? How to Invest in Them
- Pagaya Technologies: An AI Fintech That Insiders Are Buying
- Roth IRA Calculator: Calculate Your Potential Returns
- Higher Oil Prices Could Give NextEra’s Stock Earnings a Boost
Receive News & Ratings for Plexus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Plexus and related companies with MarketBeat.com's FREE daily email newsletter.